Michael H. Pillinger

VA NY Harbor Healthcare System — United States

Medicine · Health Sciences

59h-index16.8kcitations317works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gout, Hyperuricemia, Uric Acid(146), Case Reports on Hematomas(51), Inflammasome and immune disorders(37), Urticaria and Related Conditions(33), Inflammatory mediators and NSAID effects(22)

Publications310 total

Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy
Lara D. Veeken·2025
Climate Change, Environmental Risk Factors, and Gout
Arthritis Care & Research·2025Open Access
Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review
Gout Urate and Crystal Deposition Disease·2025Open Access
Risk of New-Onset CKD, Kidney Failure, and Mortality in Patients with Uncontrolled Gout vs. Controlled Gout
Journal of the American Society of Nephrology·2025
New perspectives on the NLRP3 inflammasome—colchicine and the suppression of inflammatory pathways in metabolic syndrome associated diseases
Exploration of Musculoskeletal Diseases·2025Open Access
Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial
Arthritis Care & Research·2025Open Access
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial
Seminars in Arthritis and Rheumatism·2025
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti‐Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout
Arthritis & Rheumatology·2025
Gout, Hyperuricemia, and the Intestinal Microbiome
Inflammation·2025· 2 citedOpen Access
Endothelial Cell and Neutrophil Activation in Untreated Intercritical Patients With Gout
The Journal of Rheumatology·2025· 1 citedOpen Access
Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model
Rheumatology and Therapy·2025· 1 citedOpen Access
Mentoring Underrepresented Minority Physician-Scientists to Success
UNC Libraries·2025Open Access
The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms
ACR Open Rheumatology·2025· 2 citedOpen Access
The Fifth Element: Is Vascular Dysfunction an Intrinsic Feature of Gout?
Seminars in Arthritis and Rheumatism·2025· 3 citedOpen Access
How URAT1 inhibitors can shape the future of chronic gout treatment: a narrative review of uricosurics past and present
Exploration of Musculoskeletal Diseases·2024Open Access
Neutrophil Activation and Adhesiveness in Coronary Artery Disease: Results From the COLCHICINE‐PCI Biomarker Substudy
Journal of the American Heart Association·2024· 3 citedOpen Access
Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis
Rheumatology and Therapy·2024· 3 citedOpen Access
Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial
Arthritis & Rheumatology·2024· 7 citedOpen Access
Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial
American Journal of Kidney Diseases·2024· 11 cited
AB0114 INFLUENCE OF ACUTE GOUT FLARE AND SERUM URATE LOWERING ON BIOMARKERS OF SYSTEMIC INFLAMMATION
Annals of the Rheumatic Diseases·2024
page 1 of 16Next →

Frequent Co-authors

Binita Shah(10), Steven B. Abramson(9), Tuhina Neogi(6), Robert Terkeltaub(6), John FitzGerald(5), Jasvinder A. Singh(5), Nicola Dalbeth(5), Aryeh M. Abeles(5), Svetlana Krasnokutsky(5), Bruce N. Cronstein(5), Dinesh Khanna(4), Sangmee Bae(4), Hyon K. Choi(4), Charles M. King(4), Gerald Levy(4), Neil S. Wenger(4), Puja Khanna(4), José U. Scher(4), Mukundan Attur(4), Gerald Weissmann(4)